Lori Rink

1.3k total citations
33 papers, 960 citations indexed

About

Lori Rink is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lori Rink has authored 33 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Gastroenterology, 19 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Lori Rink's work include Gastrointestinal Tumor Research and Treatment (21 papers), Sarcoma Diagnosis and Treatment (12 papers) and Gastrointestinal disorders and treatments (8 papers). Lori Rink is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (21 papers), Sarcoma Diagnosis and Treatment (12 papers) and Gastrointestinal disorders and treatments (8 papers). Lori Rink collaborates with scholars based in United States, Poland and Australia. Lori Rink's co-authors include Andrew K. Godwin, Margaret von Mehren, Burton Eisenberg, Douglas B. Flieder, Martin G. Belinsky, Chi Tarn, Safinur Atay, Jennifer Crow, Geetika Sethi and Samagya Banskota and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Lori Rink

32 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Rink United States 18 443 423 365 195 183 33 960
Troy Bainbridge United States 7 530 1.2× 512 1.2× 232 0.6× 247 1.3× 55 0.3× 7 1.1k
Gina Z. D’Amato United States 16 538 1.2× 1.0k 2.4× 244 0.7× 280 1.4× 91 0.5× 75 1.3k
Marcel Trautmann Germany 19 88 0.2× 430 1.0× 216 0.6× 96 0.5× 93 0.5× 48 781
Claudia Valverde Spain 20 283 0.6× 688 1.6× 168 0.5× 341 1.7× 80 0.4× 84 1.1k
Umio Yamaguchi Japan 18 123 0.3× 573 1.4× 214 0.6× 154 0.8× 166 0.9× 28 1.0k
Antonio De Leo Italy 17 88 0.2× 230 0.5× 191 0.5× 164 0.8× 155 0.8× 101 869
Helene Geddert Germany 26 97 0.2× 491 1.2× 666 1.8× 485 2.5× 183 1.0× 49 1.7k
Elena Conca Italy 16 234 0.5× 808 1.9× 146 0.4× 131 0.7× 80 0.4× 38 1.1k
Chueh‐Chuan Yen Taiwan 19 105 0.2× 377 0.9× 203 0.6× 221 1.1× 73 0.4× 58 930
Federico Buffoli Italy 19 148 0.3× 532 1.3× 171 0.5× 618 3.2× 115 0.6× 45 1.2k

Countries citing papers authored by Lori Rink

Since Specialization
Citations

This map shows the geographic impact of Lori Rink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Rink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Rink more than expected).

Fields of papers citing papers by Lori Rink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Rink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Rink. The network helps show where Lori Rink may publish in the future.

Co-authorship network of co-authors of Lori Rink

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Rink. A scholar is included among the top collaborators of Lori Rink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Rink. Lori Rink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Snyder, Nathaniel W., et al.. (2025). Metabolic Effects of Succinate Dehydrogenase Loss in Cancer. Journal of Cellular Physiology. 240(7). e70066–e70066.
2.
Wilson, R. Paul, Lori Rink, & Çağla Tükel. (2025). Microbiota and cancer: unraveling the significant influence of microbial communities on cancer treatment. Cancer and Metastasis Reviews. 44(2). 42–42. 1 indexed citations
3.
Movva, Sujana, Elizabeth A. Handorf, Edwin Choy, et al.. (2023). SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS). Clinical Cancer Research. 30(2). 315–322. 14 indexed citations
4.
Ye, Shuai, Martin G. Belinsky, Jeffrey M. Farma, et al.. (2021). Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor. Cancers. 13(15). 3699–3699. 4 indexed citations
5.
Ye, Shuai, Lillian R. Klug, Martin G. Belinsky, et al.. (2020). Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment. JCI Insight. 6(2). 6 indexed citations
6.
Movva, Sujana, Margaret von Mehren, Elizabeth A. Handorf, et al.. (2020). SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).. Journal of Clinical Oncology. 38(15_suppl). 11544–11544. 9 indexed citations
7.
Belinsky, Martin G., Kathy Q. Cai, Yan Zhou, et al.. (2017). Succinate dehydrogenase deficiency in a PDGFRA mutated GIST. BMC Cancer. 17(1). 512–512. 17 indexed citations
8.
Pathak, Harsh B., Martin G. Belinsky, Karthik Devarajan, et al.. (2016). Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor. Clinical Cancer Research. 23(1). 171–180. 30 indexed citations
9.
Belinsky, Martin G., Lori Rink, Kathy Q. Cai, et al.. (2015). Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case. BMC Cancer. 15(1). 887–887. 26 indexed citations
10.
Hensley, Harvey H., Karthik Devarajan, James R. Johnson, et al.. (2014). Evaluating new therapies in gastrointestinal stromal tumor using in vivo molecular optical imaging. Cancer Biology & Therapy. 15(7). 911–918. 2 indexed citations
11.
Rink, Lori, et al.. (2014). Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study. World Journal of Surgical Oncology. 12(1). 231–231. 31 indexed citations
12.
Abbeele, Annick D. Van den, Constantine Gatsonis, D.J. de Vries, et al.. (2012). ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression. Journal of Nuclear Medicine. 53(4). 567–574. 36 indexed citations
13.
Belinsky, Martin G., Lori Rink, Douglas B. Flieder, et al.. (2012). Overexpression of insulin‐like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild‐type SDHB‐negative gastrointestinal stromal tumors. Genes Chromosomes and Cancer. 52(2). 214–224. 49 indexed citations
14.
Dumont, Agathe, Lori Rink, Andrew K. Godwin, et al.. (2011). A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Annals of Oncology. 23(5). 1335–1340. 33 indexed citations
15.
Soybel, David I., Jonathan E. Kohler, & Lori Rink. (2011). Zinc and the gastrointestinal tract.. 448–472. 3 indexed citations
16.
Ochs, Michael F., Lori Rink, Chi Tarn, et al.. (2009). Detection of Treatment-Induced Changes in Signaling Pathways in Gastrointestinal Stromal Tumors Using Transcriptomic Data. Cancer Research. 69(23). 9125–9132. 43 indexed citations
17.
Belinsky, Martin G., Yuliya Skorobogatko, Lori Rink, et al.. (2009). High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes and Cancer. 48(10). 886–896. 33 indexed citations
18.
Rink, Lori & Andrew K. Godwin. (2009). Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population. Current Oncology Reports. 11(4). 314–321. 26 indexed citations
19.
Tarn, Chi, Lori Rink, Erin Merkel, et al.. (2008). Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proceedings of the National Academy of Sciences. 105(24). 8387–8392. 197 indexed citations
20.
Belinsky, Martin G., Lori Rink, Kathy Q. Cai, et al.. (2008). The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors. Cell Cycle. 7(19). 2949–2955. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Troy Bainbridge Breakdown of academic impact, for papers by Gina Z. D’Amato Breakdown of academic impact, for papers by Marcel Trautmann Breakdown of academic impact, for papers by Claudia Valverde Breakdown of academic impact, for papers by Umio Yamaguchi Breakdown of academic impact, for papers by Antonio De Leo Breakdown of academic impact, for papers by Helene Geddert Breakdown of academic impact, for papers by Elena Conca Breakdown of academic impact, for papers by Chueh‐Chuan Yen Breakdown of academic impact, for papers by Federico Buffoli
Rankless by CCL
2026